Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-05-02 00:00:00 ET · period of report 2024-04-30 · accession 0001415889-24-012018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-02 | 2024-04-30 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +1,042 | 105.3K | +1.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2024-04-30 | A | A | 1,042 | $0.00 | 105,313 | D | — | — | (F1) Represents shares released from restriction from shares awarded 3-31-2023. |